Literature DB >> 6995341

Activation of the alternative pathway of complement by mycobacteria and cord factor.

V D Ramanathan, J Curtis, J L Turk.   

Abstract

The ability of a number of mycobacteria and some of their components to activate complement was examined. Mycobacterium bovis BCG (Glaxo strain), Mycobacterium leprae, Mycobacterium lepraemurium, and cord factor activated the alternative pathway of complement in normal human serum and normal and C4-deficient guinea pig sera and generated biologically active products. BCG (Pasteur strain) and muramyl dipeptide did not activate complement. The relevance of activation of complement by mycobacteria to their induction of granulomas is discussed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6995341      PMCID： PMC551070          DOI： 10.1128/iai.29.1.30-35.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  23 in total

1.  Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.

Authors:  J UNGAR; P W MUGGLETON; J A DUDLEY; M I GRIFFITHS
Journal:  Br Med J       Date:  1962-10-27

2.  Experimental design for bioassay of a material inducing strong tachyphylactic effect (anaphylatoxin).

Authors:  E M ROCHA SILVA; A M ROTHSCHILD
Journal:  Br J Pharmacol Chemother       Date:  1956-09

3.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

4.  Activation of the alternative pathway of complement by Entamoeba histolytica.

Authors:  L Ortiz-Ortiz; R Capin; N R Capin; B Sepúlveda; G Zamacona
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

5.  The walls of Mycobacterium lepraemurium: chemistry and ultrastructure.

Authors:  P Draper
Journal:  J Gen Microbiol       Date:  1971-12

6.  Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.

Authors:  D Bitter-Suermann; U Hadding; F Melchert; H J Wellensiek
Journal:  Immunochemistry       Date:  1970-12

7.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

9.  Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system.

Authors:  D Bitter-Suermann; U Hadding; H U Schorlemmer; M Limbert; M Dierich; P Dukor
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

10.  Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.

Authors:  F T Saulsbury; J A Winkelstein
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441
View more
  13 in total

1.  A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; April N Abbott; Shen-An Hwang; Jessica Indrigo; Lisa Y Armitige; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Microbiology (Reading)       Date:  2008-06       Impact factor: 2.777

2.  Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.

Authors:  Chunfang Gu; Sarah A Jenkins; Qiong Xue; Yi Xu
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

3.  Reduced complement-mediated immune complex solubilization in leprosy patients.

Authors:  V D Ramanathan; P Sharma; G Ramu; U Sengupta
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

4.  Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.

Authors:  L S Schlesinger; M A Horwitz
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Vaccination of rabbits against Entamoeba histolytica with aqueous suspensions of trehalose-dimycolate as the adjuvant.

Authors:  A Sharma; A Haq; S Ahmad; E Lederer
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

6.  Activation of rat alveolar macrophages and protection against i.v. injected tumor cells by intratracheal administration of trehalose dimycolate.

Authors:  D Nolibe; R Masse; J P Tenu; M Lepoivre; J F Petit
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid.

Authors:  J Scott Ferguson; Jeremy J Weis; Jennifer L Martin; Larry S Schlesinger
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Differences in uptake of mycobacteria by human monocytes: a role for complement.

Authors:  R P Swartz; D Naai; C W Vogel; H Yeager
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Interactions of killed Listeria monocytogenes with the mouse complement system.

Authors:  K P van Kessel; A C Antonissen; H van Dijk; P M Rademaker; J M Willers
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Interactions of Mycobacterium lepraemurium with resident peritoneal macrophages; phagocytosis and stimulation of the oxidative burst.

Authors:  S J Brett; R Butler
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.